Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for American Healthcare REIT, Inc. (NYSE: AHR), a healthcare-focused real estate investment trust. As an issuer with common stock registered under Section 12(b) of the Securities Exchange Act of 1934, American Healthcare REIT files current reports on Form 8-K and other documents that disclose material events, financial results, capital markets transactions, governance matters and distribution declarations.
In its Form 8-K filings, the company reports quarterly earnings releases and supplemental financial data, including metrics such as GAAP net income attributable to controlling interest, Normalized Funds from Operations (NFFO) per diluted share and Same-Store Net Operating Income (NOI) growth by segment. Filings also describe acquisition and development activity across its integrated senior health campuses (ISHC), outpatient medical, triple-net leased properties and senior housing operating properties (SHOP) segments, as well as lease buyouts and dispositions of non-core properties.
American Healthcare REIT’s SEC filings further detail capital markets activity, such as public offerings of common stock on a forward basis, at-the-market (ATM) equity offering programs and related underwriting and forward sale agreements. The company discloses how it intends to contribute net proceeds to its operating partnership for general corporate purposes, including potential future investments. Additional filings report on quarterly cash distributions authorized by the board of directors, annual meeting voting results, equity plans and corporate responsibility reporting.
On Stock Titan, AI-powered tools can help interpret these filings by summarizing key terms, highlighting segment-level performance disclosures and clarifying the implications of equity offerings, distributions and governance actions. This allows readers to review American Healthcare REIT, Inc.’s regulatory history and understand how the company describes its financial condition, portfolio management and capital structure in official SEC documents.
American Healthcare REIT (AHR) filed a Form 4 disclosing that director Scott A. Estes received 3,042 restricted common shares on June 25 2025 upon his re-election to the board.
The grant was made at $0 cost and will vest on June 25 2026. Following the award, Estes' direct ownership increased to 18,895 shares, implying the new grant represents roughly 19 % of his post-transaction holdings.
No derivative securities, sales, or open-market purchases were reported, and the filing contains no additional financial information or risk disclosures.
American Healthcare REIT (NYSE:AHR) filed a Form 4 disclosing that Non-Executive Chairman and Director Jeffrey T. Hanson received 3,042 restricted common shares on 25 Jun 2025 following his re-election to the board. The grant was made at $0 cost and will vest in full on 25 Jun 2026.
Post-transaction, Hanson holds 41,808 shares directly and 85,163 shares indirectly through family trusts, retirement accounts and pension plans, bringing his total reported beneficial ownership to roughly 126,971 AHR shares. The filing also notes that securities held by NCT-107, LLC—a charitable foundation in which Hanson lacks pecuniary interest—will no longer be included in his Section 16 reports.
Form 144 Notice filed by Stefan K.L. Oh, an officer of American Healthcare REIT, indicating a proposed sale of 3,860 shares of common stock with an aggregate market value of $138,689.80 on the NYSE. The sale is scheduled for June 27, 2025.
The securities were originally acquired through an open market purchase on February 2, 2015, with cash payment. The company's total shares outstanding are 159,496,793. The sale will be executed through Charles Schwab & Co.
Key points:
- Sale represents approximately 0.002% of total shares outstanding
- Average price per share: $35.93
- No other securities were sold by the officer in the past 3 months
- Officer confirms no knowledge of undisclosed material adverse information
American Healthcare REIT (NYSE:AHR) filed an 8-K disclosing results from its June 25, 2025 Annual Meeting.
- Nine directors were re-elected for one-year terms ending in 2026.
- Shareholders ratified Deloitte & Touche LLP as independent auditor for FY 2025 (138.4 M for / 1.1 M against).
- Say-on-pay for 2024 executive compensation passed (109.3 M for / 7.5 M against).
- The 2025 Manager Equity Plan was approved (112.6 M for / 4.3 M against).
No other matters were brought to a vote.
On June 20, 2025, American Healthcare REIT, Inc. (NYSE: AHR) filed a Form 8-K to announce its second-quarter 2025 cash distribution.
The board authorized a quarterly dividend of $0.25 per common share, equal to an annualized rate of $1.00. Shareholders of record at the close of business on June 30, 2025, will receive the payment on or about July 18, 2025, funded solely from legally available funds.
No additional financial results, transactions, or strategic updates were disclosed in this report.